Remedent Stock

Remedent Market capitalization 2024

Remedent Market capitalization

999,798.5 USD

Ticker

REMI

ISIN

US75954T1043

WKN

A0ERVL

In 2024, Remedent's market cap stood at 999,798.5 USD, a -68.75% increase from the 3.2 M USD market cap in the previous year.

The Remedent Market capitalization history

YEARMarket Capitalization (undefined USD)
20221
20213.7
20203.1
20193.4
20184.7
20175.22
20163.39
20155.54
20146.78
20133.03
20125.51
20117.68
20107.47
200910.63
200821.37
200722.81
200622.02
20055.15
20043.75
20032.44

Remedent Aktienanalyse

What does Remedent do?

Remedent Inc is a company specialized in the development, manufacturing, and marketing of innovative dental products. It was founded in 1997 by Jürgen Steenwelle and Philippe de Bergeyck, with its headquarters in Mariakerke, Belgium. The company started with the creation of the GlamSmile veneer system, which revolutionized aesthetic dentistry. Remedent expanded its product portfolio to include teeth whitening systems, dental implants, dental instruments, and dental software solutions. The company aims to revolutionize the dental market with innovative technologies and materials. Remedent works closely with dental professionals worldwide to ensure the highest quality standards. It has locations in Europe, the USA, and Asia. Partnership with dentists and clinics is a key aspect of Remedent's business model, offering training and certifications to ensure proper and effective use of their products. The company is focused on global market expansion through strategic acquisitions and mergers to grow its customer base and promote technological advancements. Remedent has achieved impressive growth and success in a highly competitive market, remaining a significant provider of dental products and pursuing a strong growth strategy. Remedent ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Remedent's Market Capitalization

Remedent's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Remedent's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Remedent's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Remedent’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Remedent stock

What is the current Remedent market capitalization?

The current market capitalization of Remedent is 999,798.5 USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Remedent.

How has the market capitalization of Remedent developed in recent years?

The market capitalization of Remedent has increased/decreased by -68.75% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Remedent?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Remedent?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Remedent have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Remedent pay?

Over the past 12 months, Remedent paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Remedent is expected to pay a dividend of 0 USD.

What is the dividend yield of Remedent?

The current dividend yield of Remedent is .

When does Remedent pay dividends?

Remedent pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Remedent?

Remedent paid dividends every year for the past 0 years.

What is the dividend of Remedent?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Remedent located?

Remedent is assigned to the 'Health' sector.

Wann musste ich die Aktien von Remedent kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Remedent from 10/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/3/2024.

When did Remedent pay the last dividend?

The last dividend was paid out on 10/3/2024.

What was the dividend of Remedent in the year 2023?

In the year 2023, Remedent distributed 0 USD as dividends.

In which currency does Remedent pay out the dividend?

The dividends of Remedent are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Remedent

Our stock analysis for Remedent Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Remedent Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.